Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Icu Medical (ICUI) EBITDA Margin (2016 - 2025)

Icu Medical (ICUI) has disclosed EBITDA Margin for 17 consecutive years, with 1.04% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 494.0% year-over-year to 1.04%, compared with a TTM value of 1.92% through Dec 2025, up 12.0%, and an annual FY2025 reading of 1.92%, up 12.0% over the prior year.
  • EBITDA Margin was 1.04% for Q4 2025 at Icu Medical, down from 2.55% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 11.42% in Q3 2021 and bottomed at 7.76% in Q1 2022.
  • Average EBITDA Margin over 5 years is 2.41%, with a median of 1.53% recorded in 2024.
  • The sharpest move saw EBITDA Margin crashed -1612bps in 2022, then surged 941bps in 2023.
  • Year by year, EBITDA Margin stood at 7.0% in 2021, then tumbled by -101bps to 0.04% in 2022, then plummeted by -5296bps to 2.07% in 2023, then surged by 389bps to 5.98% in 2024, then crashed by -83bps to 1.04% in 2025.
  • Business Quant data shows EBITDA Margin for ICUI at 1.04% in Q4 2025, 2.55% in Q3 2025, and 1.93% in Q2 2025.